References
- Kantarjian HM, O’Brien S, Smith TL, . Results of treatment with hyper-CVAD, a dose-intensive regimen, in acute lymphocytic leukemia. J Clin Oncol 2000;18:547–561.
- Rodriguez V, Hart JS, Freireich EJ, . POMP combination chemotherapy of adult acute leukemia. Cancer 1973;32:69–75.
- He X, Wu D, Sun A. Extramedullary relapse following allogeneic BMT in a postpartum female patient with acute lymphoblastic leukemia. Bone Marrow Transplant 2011;47:598–599.
- Wright TL, Bardy PG, Disney P, . Isolated cardiac recurrence of acute lymphoblastic leukemia characterized by t(11;19) two years after unrelated allogeneic bone marrow transplantation. Cancer Genet Cytogenet 2002;137:146–149.
- Cunningham I. Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma 2006;47:1754–1767.
- Hardisty RM, McElwain TJ, Darby CW. Vincristine and prednisone for the induction of remissions in acute childhood leukaemia. Br Med J 1969;14:662–665.
- Shin JY, Lee SK, Kang CD, . Antitumor effect of intratumoral administration of dendritic cell combination with vincristine chemotherapy in a murine fibrosarcoma model. Histol Histopathol 2003;18:435–447.
- Grigg A, Kannan K, Schwarer AP, . Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation. Intern Med J 2001;31:15–22.
- Arellano ML, Langston A, Winton E, . Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. Biol Blood Marrow Transplant 2007;13:116–123.
- Porter DL, Roth MS, McGargle C, . Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994;330:100–106.
- Pawelec G, Da Silva P, Max H, . Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha. Leuk Lymphoma 1995;18:471–478.
- Robb RJ, Hill GR. The interferon-dependent orchestration of innate and adaptive immunity after transplantation. Blood 2012;119:5351–5358.
- Parmiani G, Castelli C, Pilla L, . Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients. Ann Oncol 2007;18:226–232.
- Chen X, Regn S, Raffegerst S, . Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia. Br J Haematol 2000;111:596–607.
- Veerman AJ, Kamps WA, van den Berg H, . Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004). Lancet Oncol 2009;10:957–966.